Sone Capital Management LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 65,402 shares of the financial services provider's stock, valued at approximately $10,901,000.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Brighton Jones LLC increased its position in Marsh & McLennan Companies by 51.2% in the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock valued at $1,856,000 after buying an additional 2,960 shares in the last quarter. Bison Wealth LLC boosted its holdings in Marsh & McLennan Companies by 39.6% in the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider's stock worth $651,000 after acquiring an additional 869 shares in the last quarter. Glenview Trust co grew its stake in Marsh & McLennan Companies by 10.8% in the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider's stock valued at $852,000 after acquiring an additional 379 shares during the period. Osterweis Capital Management Inc. raised its position in shares of Marsh & McLennan Companies by 18,440.0% during the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider's stock worth $203,000 after purchasing an additional 922 shares during the period. Finally, Diversify Advisory Services LLC bought a new stake in Marsh & McLennan Companies during the 2nd quarter valued at $1,307,000. 87.99% of the stock is owned by institutional investors.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies stock opened at $194.61 on Tuesday. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $211.28. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22. The stock's 50-day moving average price is $180.45. The stock has a market capitalization of $92.87 billion, a PE ratio of 23.79, a PEG ratio of 2.75 and a beta of 0.59.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The firm had revenue of $7.28 billion during the quarter. The company's revenue for the quarter was up 6.2% on a year-over-year basis. As a group, analysts predict that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were issued a dividend of $0.99 per share. This represents a $3.96 dividend on an annualized basis and a yield of 2.0%. This is an increase from Marsh & McLennan Companies's previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. Marsh & McLennan Companies's dividend payout ratio is 48.41%.
Insiders Place Their Bets
In other Marsh & McLennan Companies news, SVP Paul Beswick sold 713 shares of the company's stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the completion of the transaction, the senior vice president owned 16,376 shares in the company, valued at $3,242,448. This represents a 4.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Martin South sold 7,100 shares of the firm's stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total value of $1,348,929.00. Following the sale, the insider directly owned 16,632 shares of the company's stock, valued at approximately $3,159,913.68. This represents a 29.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 36,469 shares of company stock worth $6,291,345 in the last ninety days. Company insiders own 0.38% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on MRSH shares. JPMorgan Chase & Co. lifted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an "overweight" rating in a report on Monday, July 13th. Cantor Fitzgerald raised their price target on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an "overweight" rating in a research report on Thursday, July 9th. UBS Group boosted their price objective on Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a "buy" rating in a report on Monday, July 27th. Weiss Ratings upgraded Marsh & McLennan Companies from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, August 7th. Finally, Citigroup cut Marsh & McLennan Companies from a "buy" rating to a "neutral" rating and set a $200.00 target price on the stock. in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $203.50.
Get Our Latest Research Report on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
